O'Brien T G, Saladik D, Diamond L
Cancer Res. 1982 Apr;42(4):1233-8.
The progression of normal Syrian hamster embryo cells to a neoplastic phenotype after treatment with a chemical carcinogen and continuous exposure to phorbol ester tumor promoters was studied in cell culture. Tumor promoters were able to rescue cell lines derived from individual carcinogen-treated colonies from a program of cellular senescence. In general, these cell lines did not grow in soft-agar medium or produce tumors in newborn hamsters at early passages but acquired these properties at later passages. These cell lines were used to study the temporal acquisition of a phenotypic characteristic of neoplastic rather than normal hamster embryo cells: the synergistic induction of the enzyme ornithine decarboxylase (ODC) by tumor promoter and serum growth factors (O'Brien, T. G., Saladik, D., and Diamond, L. Regulation of polyamine biosynthesis in normal and transformed hamster cells in culture. Biochim. Biophys. Acta, 632: 270, 1980). All cell lines that acquired neoplastic status with passage in culture exhibited the synergistic induction of ODC prior to their acquisition of the ability to either grow in soft-agar medium or produce tumors in newborn hamsters. Cell lines that responded to promoters with the synergistic induction of ODC accumulated greater levels of polyamines, especially putrescine, after promoter treatment than did normal cells. Tumor promoters did not affect the percentage of cells labeled with [3H]thymidine in preneoplastic cell lines, a finding similar to previous results in normal and neoplastic hamster cells. These studies demonstrate that tumor promoters can affect the early stages of neoplastic progression in carcinogen-treated Syrian hamster embryo cells and that a particular phenotypic property found in neoplastic hamster cells, the synergistic induction of ODC by tumor promoters and serum growth factors, is acquired by cell lines before they acquire neoplastic potential.
在细胞培养中研究了正常叙利亚仓鼠胚胎细胞在用化学致癌物处理并持续暴露于佛波酯肿瘤促进剂后向肿瘤表型的转变。肿瘤促进剂能够挽救从单个致癌物处理的集落衍生的细胞系,使其免于细胞衰老程序。一般来说,这些细胞系在早期传代时不能在软琼脂培养基中生长或在新生仓鼠中产生肿瘤,但在后期传代时获得了这些特性。这些细胞系用于研究肿瘤性而非正常仓鼠胚胎细胞表型特征的时间性获得:肿瘤促进剂和血清生长因子对鸟氨酸脱羧酶(ODC)的协同诱导作用(奥布赖恩,T.G.,萨拉迪克,D.,和戴蒙德,L.培养的正常和转化仓鼠细胞中多胺生物合成的调节。生物化学与生物物理学学报,632:270,1980)。所有在培养传代过程中获得肿瘤状态的细胞系在获得在软琼脂培养基中生长或在新生仓鼠中产生肿瘤的能力之前,都表现出ODC的协同诱导作用。在用促进剂处理后,对促进剂有ODC协同诱导反应的细胞系比正常细胞积累了更高水平的多胺,尤其是腐胺。肿瘤促进剂不影响癌前细胞系中用[3H]胸腺嘧啶核苷标记的细胞百分比,这一发现与先前在正常和肿瘤性仓鼠细胞中的结果相似。这些研究表明,肿瘤促进剂可影响致癌物处理的叙利亚仓鼠胚胎细胞肿瘤进展的早期阶段,并且肿瘤性仓鼠细胞中发现的一种特定表型特性,即肿瘤促进剂和血清生长因子对ODC的协同诱导作用,在细胞系获得肿瘤潜能之前就已获得。